|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Jun 30, 2024
|
FY2022
12 months to Jun 30, 2023
|
FY2021
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Research and development expenses | |||||
| Acquisition-related costs (note 5) | |||||
| General and administrative expenses | |||||
| Operating Loss | |||||
| Other (Expense) Income: | |||||
| Foreign exchange | |||||
| Interest - net | |||||
| Other income | |||||
| Employee Retention Tax Credit | |||||
| Grant income | |||||
| Interest expense | |||||
| Interest income | |||||
| Change in fair value of derivative liability | |||||
| Change in fair value of Kineta merger holdback shares | |||||
| Loss on Kineta employee separation payments assumed from merger | |||||
| Total Other Income (Expense) | |||||
| Net Loss | |||||
| Deemed dividend recognized on beneficial conversion features of Series C Preferred stock issuance | |||||
| Series A Preferred cash dividend | |||||
| Series C Preferred stock dividend | |||||
| Series C Preferred Stock | |||||
| Total series C Preferred stock dividend | |||||
| Deemed dividend on warrant modifications | |||||
| Net Loss attributable to common stockholders | |||||
| Net Loss per share, basic | |||||
| Net Loss per share, diluted | |||||
| Weighted-average shares outstanding, basic | |||||
| Weighted-average shares outstanding, diluted |
Loading...